Home Metsera

Metsera

acquired
IPO Delisting
Obesity Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Metsera Therapeutics, a new obesity drug startup operating in stealth mode, has licensed six obesity drug candidates from D&D Pharmatech.
Metsera, Inc.
NewYork,NewYork,United States of America
15~50 people
January 01, 2022
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Concept
Therapeutic Products # Diabetes Mellitus Obesity
Application Scenarios
Innovative Drugs

LinkedIn